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Abstract
Cognitive enhancement (CE) is the pharmaceutical augmentation of mental abilities (e.g., learning or memory) without
medical necessity. This topic has recently attracted widespread attention in scientific and social circles. However, knowledge
regarding the mechanisms that underlie the decision to use CE medication is limited. To analyze these decisions, we used
data from two online surveys of randomly sampled university teachers (N= 1,406) and students (N = 3,486). Each respondent
evaluated one randomly selected vignette with regard to a hypothetical CE drug. We experimentally varied the
characteristics of the drugs among vignettes and distributed them among respondents. In addition, the respondent’s
internalization of social norms with respect to CE drug use was measured. Our results revealed that students were more
willing to enhance cognitive performance via drugs than university teachers, although the overall willingness was low. The
probability of side effects and their strength reduced the willingness to use CE drugs among students and university
teachers, whereas higher likelihoods and magnitudes of CE increased this propensity. In addition, the internalized norm
against CE drug use influenced decision making: Higher internalization decreased the willingness to use such medications.
Students’ internalized norms more strongly affected CE abstinence compared with those of university teachers.
Furthermore, internalized norms negatively interacted with the instrumental incentives for taking CE medication. This
internalization limited the influence of and deliberation on instrumental incentives. This study is the first to provide
empirical evidence regarding the importance of social norms and their influence on rational decision making with regard to
CE. We identified previously undiscovered decision-making patterns concerning CE. Thus, this study provides insight into
the motivators and inhibitors of CE drug use. These findings have implications for contending with CE behavior by
highlighting the magnitude of potential side effects and by informing the debate regarding the ethics of CE use.
Citation: Sattler S, Sauer C, Mehlkop G, Graeff P (2013) The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers. PLoS
ONE 8(7): e68821. doi:10.1371/journal.pone.0068821
Editor: Michael Taffe, The Scripps Research Institute, United States of America
Received January 7, 2013; Accepted June 3, 2013; Published July 17, 2013
Copyright:  2013 Sattler et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was funded by the Federal Ministry of Education and Research (FMER; grant number 01PH08024, headed by Sebastian Sattler and Martin
Diewald; http://www.bmbf.de/en/index.php). Carsten Sauer gratefully acknowledges a grant from the Bielefeld Graduate School in History and Sociology (BGHS;
http://www.uni-bielefeld.de/(en)/bghs/), and Sebastian Sattler acknowledges a Rectorate Fellowship of the Bielefeld University (grant number 3521.01; http://
www.uni-bielefeld.de/(en)/nachwuchs/finanzierung_und_foerderung/promovierende/rektoratsstipendien.html). We acknowledge support for the Article
Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funding agencies
had no role with regard to study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sebastian.sattler@uni-bielefeld.de
Introduction
Cognitive Enhancement (CE) in Academia
CE can be defined as ‘‘the amplification or extension of [the]
core capacities of the mind through improvement or [the]
augmentation of internal […] information processing systems’’
([1], p. 311). Healthy individuals may perceive CE drug use as a
benefit-seeking strategy to enhance their cognitive abilities [2–4].
Potential cognitive enhancing medications include methylpheni-
date, (dextro-) amphetamine, donepezil, and modafinil [5,6].
These drugs are prescribed as treatment for a variety of disorders,
including attention deficit hyperactivity disorder (ADHD), postural
orthostatic tachycardia syndrome, Alzheimer’s disease or demen-
tia, shift work sleep disorder, and narcolepsy (e.g., [4,7]).
Some authors predict that CE will be a forthcoming trend that
will shape history and herald a 21st century of neuroscience [8].
One reason for this trend might be increasing pressure at work due
to increased competition and workload [9]. Therefore, CE can be
understood as an instrumental adaption to cope with these
demands [4].
University students and teachers can be seen as populations at
risk for CE drugs use [10], as success in academia depends on
‘‘brainpower’’, and a need to perform at high levels may have
increased due to competition over the last few decades (e.g., [11]).
The current prevalence rate of CE drug use is unknown.
However, one poll found that 20% of the surveyed readers of
Nature magazine [10] used drugs during their lifetime to augment
performance. In another survey, 23% of physicians in North
America were willing to use cognitive enhancers of proven efficacy
if they were approved for use and had no severe associated risks
[12]. For students, surveys suggest a lifetime prevalence of CE
drug use ranging from 3% to 11% in the U.S. [13] and 0.7% to
4.5% in Germany [14,15].
In addition, most studies only provide data concerning the
prevalence and specific interactions with sociodemographic
variables without referring to a theoretical model. Therefore, little
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is known regarding the decision-making process among CE users,
and a theoretical framework guiding empirical investigations is
needed [7,16–18].
The Mechanisms of Using Performance Enhancing Drugs
We refer to the self-medication hypothesis [19,20], which
proposes that individuals apply strategies to reduce their cognitive
interference or compensate for certain deficits despite the
potentially negative aspects of medication [21]. This non-
formalized idea approximates the general approach of the classical
Rational Choice Theory (RCT), which assumes that actors are
utility maximizers who make decisions by weighing the pros and
cons of possible action alternatives [22–24]. We adopt this idea to
explain CE drug use (cf. [4]), as consuming performance-
enhancing drugs is based on a decision-making process, which
includes the following instrumental incentives: 1) the benefit of
using CE medication to increase mental performance; 2) the
probability of achieving this benefit; 3) the costs associated with
CE drug consumption (i.e., the potential side effects); and 4) the
probability of these costs.
The desired goal of CE drug use is to increase cognitive
performance relative to an actual baseline state [1] by enhancing
concentration, allowing students to study for more hours [25] or
increasing working memory performance [26]. Boosting one’s self-
esteem or the desire to improve one’s position relative to others in
competition for prospective jobs and other assets [1,27] might be
additional reasons. Studies have shown that a low student grade
point average and highly competitive admission criteria at colleges
are associated with higher rates of the non-medical use of
prescription stimulants [17]. This finding might indicatethat CE
drug use is a strategy to attain success [15]. In addition, CE drugs
might be a means to cope with stressors and increase personal
performance [16].In general, the benefits of CE drug use are
small-to-moderate for healthy individuals [1,28], and a diminish-
ing return can be expected [26,29,30].
However, the effects vary widely across individuals (e.g., [26,29–
33]), and high-performing individuals benefit the least from CE
drugs [29,30,34]. Consequently, the desired benefits occur with a
certain likelihood.
For healthy individuals, concerns exist regarding the potential
side effects and long-term health consequences of CE drug use
(e.g., fatal arrhythmias, excitotoxicity, emesis, sexual dysfunction,
addiction, depression, sleep difficulties, reduced appetite and
weight loss as well as weight gain, hypertension, headaches, high
blood pressure, and even changes in personality; [21,27,30,34–
37]). These costs may outweigh the benefits [5]. Counterfeit
medication purchased on the Internet is particularly associated
with risks as well as unintended overdosing by self-medication
[26,34] and risks emerging from the interactions of these drugs
with other medications [37]. These negative consequences of off-
label use are largely unknown for healthy individuals [5,10].
Following the self-medication hypothesis, actors might be willing
to accept the negative effects of a substance in exchange for the
chance to achieve a desirable state [10,19]. Some evidence shows
that expected side effects of CE drugs reduce the frequency of their
use [15]. However, additional research is needed concerning the
extent to which side effects influence the decision-making process,
as little is known about how respondents react to hints or
information regarding drug characteristics [28].
These side effects do not occur with certainty, but they do occur
with a specific probability. For example, Wezenberg et al. [38]
found that 6 out of 10 healthy users of ampakine farampator (a
treatment of Alzheimer’s disease and schizophrenia that can be
used as a CE drug) suffered from headaches. This type of
information is outlined in instructional leaflets for medically
prescribed drugs; however the validity of such information for
healthy users is unclear. Therefore, individuals must evaluate the
likelihood of side effects before engaging in self-medication [27].
Rejecting or verifying the assumption of ‘‘naive users’’ will
improve our understanding of the mechanisms that underlie CE
drug use [39].
In addition to the variables considered by classical RCT, the
normative dimensions of CE drug use (cf. [8,28,40]) must be
explored for the following reasons: CE drugs might be perceived as
an unfair means to gain advantages relative to others, which may
place pressure on non-users to also use drugs [1,21] and may
infringe on others’ freedom of choice [8]. Furthermore, unequal
access (e.g., because of financial restrictions) can violate the norms
of fairness [3]. In addition, the violation of authenticity norms has
been discussed via the implication that ‘‘native or achieved
excellence has a higher worth than talent that is bought’’ ([1], p.
326). Using medication for another purpose might be socially
prohibited or taboo and can be regarded as a socially undesirable
abuse of drugs. Actually, little is known about how potential users
make decisions with regard to this normative dimension [28].
According to Hechter and Opp [41], social norms can be
defined as moral imperatives (i.e., social actions that should (or
should not) be processed without taking in account consequences
for the actor) or more generally as guidelines for individual actions
in the absence of moral imperatives. We propose that the social
norms that prohibit CE drug use have not been internalized to the
same degree across all actors.
Some scholars argue that following or violating a norm can be
regarded as rational behavior [42,43]. Although breaking a norm
can result in internal penalties such as psychological costs,
following an internalized norm can result in intrinsic rewards
[43,44]. Several studies have provided evidence that norms are
crucial determinants of behavior (e.g., [45,46]). Considering
internalized norms as psychological incentives breaks with the
traditional assumption in RCT that actors hold preferences only
for tangible or ‘‘hard’’ incentives [47]. Extending RCT models
using the concepts of social psychology is helpful in predicting
behavior [48]. A person’s willingness to take CE drugs is expected
to decrease as internalized norms against CE use become stronger.
Other scholars posit that social norms should not be regarded as
a part of a rational decision-making process [49,50], i.e., by
prescribing behavior in unconditional and non-outcome-oriented
ways [51–53]. If a potential action is classified as ‘‘wrong’’ due to a
particular norm, then this action is more likely to be removed from
the agenda. Therefore, norms function as filters for non-
appropriate alternatives (also see [54], p. 75). Thus, deliberation
no longer becomes necessary, and benefits are weighted down,
completely ignored, or the deterring effect of the costs increases
[52,55]. Actors often rely on proven and well-known strategies
without much consideration of alternate strategies (e.g., a rule of
thumb or social norm) to reduce the costs of in-depth deliberation
[52,55]. The stronger the internalized norm, the less individuals
deliberate on the costs and benefits of CE drug use, and the more
likely individuals are to refrain from their use.
The single elements of the decision-making process according to
classical RCT can be summarized in an expected utility term
(U= q * B – p * C) where q is the probability that the drug works, B
is the increase in performance, p is the probability that side effects
will occur, and C is the severity of side effects (cf. [53,56,57]). Our
first hypothesis states that an increase in expected utility from CE
drug use increases the probability of CE drug use (H1). Second,
when individuals internalize social norms that are contrary to CE
medication use, the probability of using CE drugs decreases (H2).
The Rationale for Consuming CE Drugs
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Third, the effects of internalized norms and expected utilities will
interact in the following manner: When the norms are strongly
internalized, the effect of utility on the probability of CE drug use
will decrease (H3).
The Present Study
To understand the decision-making process regarding the use of
CE drugs, and to test the above hypotheses, we conducted two
surveys. Although pioneering studies often used small, non-
randomized and selective samples [58,59], our large-scale surveys
use randomized samples of students and an exhaustive survey of
university teachers. Within the context of a vignette study,
participants rated their willingness to take hypothetical CE drugs,
which were experimentally varied with regard to 1) increases in
mental performance and 2) the likelihood of experiencing
increases in mental performance, 3) potential side effects, and 4)
the probability of experiencing side effects. Furthermore, partic-
ipants assessed their internalized norms to abstain from CE drug
use. By analyzing the role of instrumental incentives, internalized
norms, and the interaction between the two, we gained knowledge
concerning the mechanisms that underlie the decision-making
process with respect to CE drugs.
Methods
Participants
The empirical tests of the hypotheses were based on two large
random samples of university students (N= 5,048) and university
teachers (N= 3,980). We provide the information suggested by the
Checklist for Reporting Results of Internet E-Surveys (CHER-
RIES). A three-stage random design was applied using self-
administered online surveys for students conducted in February
2011: First, four German universities were selected; second,
academic disciplines were chosen; and third, students were
randomly sampled. The same universities were used for the
sample of university teachers, and all university teachers of the
randomly chosen disciplines were contacted. A total of 3,486
students and 1,402 university teachers responded to the survey.
The student response rate was 69.1%, and the teacher response
rate was 35.3%. The completion rates of these groups were 93.1%
and 77.2% for students and teachers, respectively; these rates are
similar to those of previous studies [17,18,60–62]. The analyses
were conducted on 3,209 students and 1,064 university teachers
due to dropouts and incomplete responses. Females comprised
60.9% of the student sample and 31.1% of the teacher sample.
The median ages of students and teachers ranged between 22–23
years and 36–40 years, respectively.
Data Quality Assurance
The survey procedure provided full anonymity to ensure
privacy and obtain unbiased results (see ethics statement below).
Participation was voluntary. Participants received a pre-notifica-
tion letter in the mail that contained information concerning the
purpose of the study, data security, and the conditions of
participation. The letter was followed by an e-mail invitation
and up to two reminders. E-mail invitations contained a personal
password-protected link that prevented multiple participations.
We incentivized our participants to obtain a higher participation
rate and better data quality (e.g., [63]). Every student could choose
a reward (EUR 5 via the mail or a PayPal account, a voucher for
an online store, or one out of two receipts of charitable donations).
Academic faculty could choose from EUR 5 on a PayPal account,
a voucher for an online store or two receipts of charitable
donations. All instruments passed an extensive expert pretest
procedure. Furthermore, we conducted think-aloud pretests to
ensure the validity of our measures. The usability and technical
functionality of the survey tool (EFS Survey 8.0) were also tested.
Our instruments were presented on two pages, with the vignette
on one page and the questionnaire on internalized social norms on
another page.
Experimental Setting and Vignette Construction
We used a factorial survey approach [64,65] to test the
theoretical assumptions (studies that use vignettes, see [66,67];
for general hypothetical CE use, see [12,68]). The factorial survey
described decisional situations (so-called vignettes) across several
attributes (dimensions) that varied experimentally in their levels.
The vignettes described a fictitious university student (or teacher)
with the opportunity to use a drug to enhance his cognitive
abilities for studies (or work) without medical necessity. We
employed a factorial survey approach because it allowed us to vary
all level combinations experimentally, and this design is more
immune to socially desired answering than direct questioning due
to its hypothetical character [69–71]. The vignettes provided
information on cognitive benefits and the costs in terms of side
effects (i.e., headache) as well as the probabilities that these benefits
and costs would occur (see Table 1). Costs and benefits varied
systematically by size and the probability of occurrence. To
illustrate the dimension ‘‘magnitude of headache’’ as a side effect,
we used the Wong-Baker FACES Pain Rating Scale (Copyright
Wong-Baker FACES Foundation, www.WongBakerFACES.org;
used with permission), which is a commonly used, highly valid and
reliable method to measure pain severity [72–74]. The scale
appeared under the vignette text but was omitted in vignettes that
did not include side effects. We used all possible vignette
combinations (Nvignettes = 1,080, full factorial design) and added
the 36 combinations of q and B without side effects, thereby
yielding 1,116 vignettes in total. Each respondent was randomly
assigned to one vignette; each vignette was rated approximately
three times on average (min= 1; max= 5). The wording of the
vignettes was as follows (examples in brackets):
‘‘The next questions focus on a very recent topic. Please read the next
paragraph carefully and imagine the following situation: A university
teacher {version for students: ‘‘a student’’} considers enhancing
his cognitive performance for his work {version for students:
‘‘studies’’} by using a prescription drug without any medical necessity.
Someone can provide him with the pills for free. A study that found that
the drug increases cognitive performance by [250] percent with a
likelihood of [60] percent caught his attention. In addition, the side
effects were investigated: Using this medication causes [slight]
headaches (value [2] on the scale) for one out of [100,000] users.
Additional side effects are unknown.’’
Using the question, ‘‘Would you consume the drug if you were
in his position?’’, respondents applied a 10-point Likert-scale to
rate the likelihood of use from ‘‘strongly against use’’ (0) to
‘‘strongly in favor of use’’ (9). The number of missing responses
was low: 13 (0.4%) students and 39 (2.7%) university teachers did
not respond.
Norm Measure
The process of norm internalization involves social learning and
conditioning (i.e., via sanctions) [75] such that after successful
internalization, actors follow norms without monitoring or
sanctioning. To measure the degree to which social norms are
internalized, we referred to the Theory of Normative Internali-
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zation [76], which explains how an internalized social norm
becomes a moral commitment. Our operationalization of morals is
similar to measures used in prior studies [45,77,78]. University
students and teachers specified their respective moral commitment
with regard to the use of prescription drugs without medical
necessity using the following question: ‘‘How do you personally
evaluate using prescription drugs to enhance studying [for
university teachers, working] performance without any medical
necessity? I think this use is …’’. Evaluations were recorded using a
7-point rating scale that ranged from ‘‘absolutely moral’’ (1) to
‘‘absolutely not moral’’ (7). Items for university teachers were
‘‘…when one must work intensively on something important’’;
‘‘…during an appointment that is decisive for ones work’’; and
‘‘…generally for work’’. Items for students were ‘‘before an
examination’’; ‘‘during an examination’’; and ‘‘in general for
university studies’’. In each study, a weighted sum score based on
the three items above was calculated. Scale reliability coefficients
were satisfactory (alphastudents = 0.95; alphauniversity teachers = 0.96).
Ethics Statement
The ethical principles as formulated in the WMA Declaration of
Helsinki guided our research project. If research objectives do not
refer to issues regulated by law (e.g., the German Medicine Act
[Arzneimittelgesetz, AMG], the Medical Devices Act [Medizin-
produktegesetz, MGP], the Stem Cell Research Act [Stammzel-
lenforschungsgesetz, StFG] or the Medical Association’s Profes-
sional Code of Conduct [Berufsordnung der A¨rzte]), then no ethics
approval is required for social science research in Germany. Our
study has no such objectives; therefore, no approval was required.
Paragraph 28 of the Data Protection Act of North Rhine
Westphalia (Datenschutzgesetz Nordrhein-Westfalen, DSG
NRW) states that personal data should be used anonymously;
furthermore, it states that participant consent is only required
when the data are not anonymous. All data were anonymous.
Participation was voluntary, and people who opted not to
participate or withdrew were not penalized. Anonymity and
informed consent to use the data were communicated and
obtained through a declaration of data security and included in
all communications. Anonymity was ensured given that a) the
research team did not have access to names or addresses (e-mail or
postal); b) the cooperating universities had no data access; and c)
we used secure sockets layer (SSL) protocols. The legal services of
Bielefeld University approved all procedures. After informing
respondents of these mechanisms, participation was understood as
being conclusive action. An official data protection officer
supervised our project and data collection.
Results
First, students (mean= 1.38; sd = 0.04) showed a greater
willingness to take the cognitive enhancers described in the
vignettes than university teachers (mean= 0.77; sd = 0.05;
t =29.05; p,0.001). This difference is shown in Figure 1: All of
the lines that represent students are located above those for
university teachers.
Second, Figure 1 shows the association between the vignette
dimensions. As the performance-enhancing effect of the CE drug
(i.e., the RCT benefits [B]) increased, respondents were more
willing to take the drug. The ascending lines indicate this effect in
Panel A. In addition, increases in the probability of a performance
increase (q, Panel B) increased this willingness. Conversely, as the
magnitude of a headache (i.e., RCT costs [C, Panel C]) and the
probability of its occurrence (p, Panel D; we transformed p using its
base-10 logarithm to place it within the range of the other
variables) increased, the willingness to take CE pills decreased.
Third, these effects were tested in multivariate models (see
Models 1 and 2 in Table S1) in which we simultaneously tested for
the effect of internalized social norms [the norm internalization of
students (mean= 5.58; sd = 1.73) was lower than that of university
teachers (mean=5.23; sd = 1.82)]. The latter variable showed the
expected negative effect on the willingness to take CE drugs in
both populations (pstudents,0.001 and puniversity teachers,0.001, see
Models 1 and 2). University students and teachers with a stronger
internalized norm against CE drug use were less willing to use
these drugs.
To validate the previously described differences in the
willingness to use CE drugs, we used a pooled dataset of university
students and teachers and included a dummy variable to
indicating the population (see Model 3). Again, the positive
coefficient (p,0.001) revealed that students were more willing to
use these drugs than university teachers. Group comparison tests
were employed to test whether university students and teachers
reacted in the same way to the drug characteristics described by
the vignette dimensions and whether their norm internalization
worked equally (Model 4). These goals were accomplished by
computing the interaction effects between each vignette dimension
and the population type. The treatments influenced both types of
participants similarly because significant interactions did not exist
for the vignette dimensions. However, we found an interaction
Table 1. Vignette Dimensions, Levels, and Coding in Both Studies.
Dimension Levels Coding
Probability of
performance increase (q)
1/20/40/60/80/100 percent 0.01/0.2/0.4/0.6/0.8/1
Increase of mental
performance (B)
1/50/100/150/200/250 percent 0.01/0.5/1/1.5/2/2.5
Probability of
headache (p)
No side effects/1 out of 100,000 users/1 out of 10.000 users/1 out of 1,000
users/1 out of 100 users/1 out of 10 users/every user
0/0.00001/0.0001/0.001/0.01/0.1/1
Magnitude of
headache (C)
[No side effects]/slight headache (value 2 on the scale)/moderate headache
(value 4 on the scale)/strong headache (value 6 on the scale)/very strong
headache (value 8 on the scale)/extreme headache (value 10 on the scale)
0/0.2/0.4/0.6/0.8/1
We displayed the Wong-Baker FACESTM 10-point pain scale that uses visual
(faces with various degrees of pain), verbal (no hurt, hurts little bit, hurts little
more, hurts even more, hurts whole lot, hurts worst), and numerical cues.
doi:10.1371/journal.pone.0068821.t001
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effect for the norm variable (p,0.001): The same level of norm
internalization had a stronger negative effect on students’
willingness to use CE drugs compared with university teachers
(see Figure 2).
Fourth, classical RCT assumes that actors consider all four
instrumental determinants because individuals do not respond to
benefits and costs independent from their respective probabilities
of occurrence (i.e., even a great benefit will not motivate people to
take a drug when the probability of the effects is approximately
zero (see [79], p.39). Therefore, a composite utility measure (U)
was constructed by subtracting the weighted costs (p*C) from the
weighted benefits (q*B). In both studies, the effect of U (see Models
1 and 2 in Table S2) revealed a significant (pstudents,0.001 and
puniversity teachers,0.001) positive effect with regard to the
willingness to use the CE drug. Thus, a pill that produced a
higher performance boost while having lower side effects led to a
greater willingness to use a CE drug. This finding is in line with the
classical RCT. Nevertheless, the norm effect remained stable.
Models 3 and 4 replicated the findings from Table S1: We found
a) a greater willingness among students to use CE drugs; b) no
differences with regard to the different effects of the vignette
dimensions on utility across populations (the insignificant interac-
tion between U and the grouping variable in Table S2 indicates
this result); and c) a stronger effect of internalized norms in
students.
Fifth, our extended RCT postulated that stronger norm
internalization would decrease the effect of utility. We found
this negative interaction effect in both populations (pstu-
dents,0.001; puniversity teachers,0.001, see Models 1 and 2 in
Table S3). This effect did not differ between students and
teachers (see the interaction of U, N, and the grouping variable
in Model 4 in Table S3). As the internalization of the social
norm against CE use strengthens, the effect of the utility
decreases the willingness to use the drug. This effect can be
seen in Figure 3, which is based on Table S3. An increasing
slope indicates the increasing influence of utility. The strength of
norm internalizations modulated this influence: For university
students and teachers with strong internalizations (see the dotted
lines in Panels A and B), the slope of the lines was
approximately parallel with the x-axis; thus, utility plays
virtually no role. Conversely, the slopes were steep in case of
a weak internalization (see the drawn lines); thus, utility shows a
strong positive effect. A medium internalization (see the dashed
lines) moderately reduced the ascent of the slopes.
Discussion
We aimed to understand and explain the mechanisms
underlying prescription drug use to enhance cognitive perfor-
mance among university students and teachers. We assumed
that the use of CE drugs results from a decision-making process
Figure 1. Willingness of Students and Teachers to Use Cognitive Enhancers with Four Varying Characteristics. Each panel shows the
mean willingness to use a CE pill on a 10-point Likert scale with the following anchors: 0 = ‘‘strongly against use’’ and 9 = ‘‘strongly in favor of use’’.
Corresponding confidence intervals with local polynomial smoothing are also shown. The lines in each panel indicate a generally lower willingness to
use CE drugs for university teachers (dashed lines) compared with students (drawn lines). Mean willingness increases with increases in mental
performance (A). Mean willingness increases as the probability of performance increases (B). Mean willingness decreases as the magnitude of
headache increases (C). Mean willingness decreases as the (logarithmized) probability of headache increases (D).
doi:10.1371/journal.pone.0068821.g001
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driven by instrumental incentives and internalized social norms.
In the following section, we summarize and interpret our
findings, discuss limitations, and postulate the implications of the
study.
Summary and Interpretation of Results
Our study is among the first to use large random samples of
students and teachers to assess their willingness to use CE drugs.
While the overall willingness to use CE drugs was low, we found
Figure 2. Willingness of University Students and Teachers to Use Cognitive Enhancers Depending on Their Norm Internalizations.
The estimated mean willingness to use a CE pill was measured on a 10-point Likert scale with the following anchors: 0 = ‘‘strongly against use’’ and
9 = ‘‘strongly in favor of use’’. Corresponding confidence intervals based on Model 4 (all effects with the exception of norm internalization and the
group variable were set to their mean values) are also shown. Mean willingness decreased as a function of norm internalization. This decrease was
stronger in university students (light grey line) than teachers (black line).
doi:10.1371/journal.pone.0068821.g002
Figure 3. Willingness of Students and Teachers to Use Cognitive Enhancers Depending on Utility, Internalized Norms, and
Interactions. Each panel shows the mean willingness to use a CE pill on a 10-point Likert scale with the following anchors: 0 = ‘‘strongly against use’’
and 9 = ‘‘strongly in favor of use’’. A strong norm internalization (dotted lines), leads to a flat slope, which indicates that utility does not increase the
willingness of university students (Panel A) or teachers (B). A weak internalization (drawn lines) leads to steep slopes, which indicates that utility
strongly increases this willingness. A medium internalization (dashed lines) leads to a moderate ascent of the slopes.
doi:10.1371/journal.pone.0068821.g003
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that students were more willing than teachers to engage in CE
drug use.
The findings in both populations support the theoretical
assumptions of our modified rational-choice model: An increase
in utility boosts the probability of using CE medication. During
decision making, actors consider benefits and risks and are
therefore instrumentally oriented (cf. [4,52]). This process
indicates that users are neither naive nor exclusively benefit
oriented. Consequently, H1 was supported.
To the best of our knowledge, this is the first study using an
extended RCT model which shows that the decision to take CE
drugs is not only based on rational deliberation but also influenced
by internalized social norms. For some people, drug use without
any medical indication (i.e., an identified illness) might be seen as
normatively dubious. Furthermore, some people might perceive
conflicts with social norms such as rules of fairness or authenticity
[1,40]. The results endorse the hypothesis (H2) that deeply
internalized norms against CE drug use significantly reduce the
willingness to use them, even if their utility is controlled. This
finding can be explained by the fact that a violation of internalized
norms can result in internal penalties such as psychological costs
(e.g., [43,44,46]). We found that students are more sensitive to
internalized norms than university teachers, suggesting that
stronger internalization led students to more strongly refrain from
using CE drugs.
Our findings also support the assumption of an interaction
between utility and internalized social norms (H3) [52,53,80]. As
internalized norms against CE drug use increased, the effect of
utility on the decision to take CE medication was reduced. Actors
deliberated less on the potential utility of CE drugs. Instead, the
strong internalized norms overruled the instrumental incentives of
using CE medication as an alternative. Strongly internalized
norms work as a filter to refrain from using drugs without
deliberation [54,81,82].
Study Limitations
One limitation of this study is the relatively low response rate
among university teachers. However, with regard to other studies
in this population [61,62] and the high opportunity costs for
participation among university teachers, the achieved rate was
satisfactory.
Furthermore, this study was conducted only in Germany.
Several factors that could result in different consumption patterns
across countries (e.g., drug availability, acceptability of CE drug
use, legal status of CE substances, prices, and culturally accepted
strategies to achieve success) should be investigated in further
multi-country studies.
Because university students and teachers have a special demand
for cognitive abilities, they might have a greater need for CE
medication than other people. In addition, further studies should
be conducted to determine whether our results are generalizable to
other settings in which alertness, vigilance, or high cognitive
performance matter, especially in fields that involve continuous
productivity or repetitive work. Therefore, future studies may
apply our model to the general population with the goal of
replicating our results. However, Iit is intriguing that two groups in
different life stages showed similar decision-making patterns even
though they differed in their opportunity structure and costs. On
the one hand, university teachers might be more motivated to use
CE drugs, as competition among university teachers might be
stronger than the competition among students. On the other hand,
university teachers might have already invested a great deal into
their career. Therefore, they might have more to lose from the
social disapproval that results from (detected) CE misuse [83].
Future research could also complement the findings of our study
using an extended RCT model by embedding additional factors in
the theoretical framework (e.g., by considering variables such as
peer prevalence, personal experience, the price of CE drugs,
personal characteristics, etc.).
In this study, we investigated only the use of pharmaceutical CE
drugs. The use of other CE methods (see [1,84–86]), such as
transcranial direct current stimulation, education, mental training,
genetic modifications, prenatal enhancement, non-prescription
drugs or illegal drugs such as cocaine, requires further research. In
addition, we did not investigate other reasons for which people
choose to use CE pharmaceuticals, such as mood lifting, weight
loss, getting high, etc. [7,18], nor did we explore the type of the
participants’ pharmaceutically enhanced cognitive function that
participants might experience. It must also be noted that different
substances (e.g., methylphenidate, atomoxetine, modafinil, or
mixed amphetamine salts) vary in their desired and adverse
effects. These differences might influence the decision-making
process. However, one strength of our experimental design is that
multiple combinations of wanted and adverse effects, which might
be representative of certain classes of medication or specific
substances, were investigated. By varying the drug class and the
affected type of cognitive functioning, further studies could offer
additional insights.
Implications
Our extended RCT model enhance understanding of the
decision-making process of individuals with respect to CE drug
use. Healthcare professionals, physicians, universities, politicians,
and others can use this knowledge and our findings to regulate CE
drug use and create recommendations for policy and practice from
empirical research. These findings highlight the fact that people
consider the normative dimension of CE drug use in addition to its
side effects and benefits.
In general, society, politics, and legislation must determine
whether CE drug use should be legal and under what conditions
its use should be considered appropriate; this also applies for
universities [28]. These decisions are striking because CE drug use
implies potential health risks but can be used to attain better
personal outcomes that can also result in positive societal effects
such as research innovations. This benefit is especially true in
academia but is also true for other fields in which ‘‘brainpower’’ is
an important determinant of success. We found that the
internalized norms concerning CE drug use differed among
respondents and that these norms were a crucial element in
choosing to consume CE drugs. Regulations, such as laws or
recommendations, that influence the emergence or alteration of
internalized norms concerning CE drug use might be a way for
policymakers to influence drug consumption. One way to
regulating CE drug use among students could be mentioning
CE drug use in university honor codes. These codes define what is
right and wrong, explain sanctions, raise the awareness of students
and university teachers concerning cheating, etc. (e.g., [87]).
Research shows that a) faculty at institution with honor codes are
more likely to use judicial procedures and established procedures
for handling cheating incidents [87]; and b) students expect
stronger sanctions from faculty at institutions with such codes [87],
show less dishonesty, and rate their acceptance and understanding
of the academic integrity policy higher [87–89]. Research is
needed to investigate whether CE drug use is considered to be
cheating, as our study only demonstrates that a certain number of
students have internalized social norms against CE drug use as
well as how students would react to the regulation of CE drugs in
their universities. This topic should be addressed in future
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research. However, norm internalization not only exerts negative
main effects on drug use but also decreases the tempting effect of
higher utility when deciding whether to take CE drugs. This
mechanism strengthens the power of the drug regulations that are
intended to shape internalized norms.
Drug regulations are even more important as long as the health-
related consequences are unclear. Some scholars have raised
strong concerns because they fear serious physical or psychiatric
problems, especially when CE medication is not under medical
supervision [35]. Side effects may cause an increased demand on
the public healthcare system, which is ultimately a political issue. A
more liberal position states that the decision to use medication
should be up to competent individuals ‘‘as an expression of
autonomy’’ ([3], p. 53); however, they should also be responsible
for any negative effects [40]. The deterrence effect of side effects
found in our study can be translated into policy (potential) users
with more reliable information concerning these adverse effects
and by providing alternative strategies to help individuals reach
their desired goals [1,4]. However, potential prevention and
intervention strategies must take the varying severities and types of
side effects of different drugs into account (e.g., psychological side
effects such as addiction or physiological side effects such as fatal
arrhythmias). In addition, to avoid exaggerated expectations
among some individuals with respect to the benefits of CE drugs,
it should be communicated that, based on current knowledge of
the available drugs, the effects of such drugs are small-to-moderate
for healthy individuals [28,33].
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